Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Palliative treatment of chronic neurologic disorders.
Ten Years of Proteomics in Multiple Sclerosis.
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
[Remyelination strategy for multiple sclerosis].
Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.
Neuromyelitis optica spectrum disorders: An update.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Dramatically changing rates and reasons for hospitalization in multiple sclerosis.
Effects of prolonged fasting on fatigue and quality of life in patients with multiple sclerosis.
Case centered analysis of Optic Neuritis following vaccines.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
Podoplanin negatively regulates CD4+ effector T cell responses.
Statin treatment 0061ffects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
IL-15-secreting γδT cells induce memory T cells in experimental allergic encephalomyelitis (EAE) mice.
SIRT1 Promotes RGC Survival and Delays Loss of Function Following Optic Nerve Crush.
[Optic nerve neuritis].
Pages
« first
‹ previous
…
619
620
621
622
623
624
625
626
627
…
next ›
last »